B. Bozkurt{1}, C. Le Roux{2}, S. Wharton{3}, J. Butt{4}, Y. Ali{5}, M. Kunz{6}, S. Marshall{5}, N. J. Pagidipati{7}, K. H. Pietilainen{8}, M. Schou{9}, N. Sattar{10}, M. Sumin{6}, L. Kaplan{11};
{1}Winters Center for Heart Failure Research, Cardiovascular Research Institute, Baylor College of Medicine, Houston, TX, {2}University College Dublin School of Medicine, Dublin, IRELAND, and Ulster University, Coleraine, United Kingdom, {3}McMaster University, Hamilton, ON and University of Toronto, Toronto, ON, Canada, {4}University of Glasgow, Glasgow, UNITED KINGDOM; Rigshospitalet Copenhagen University Hospital, Copenhagen, DENMARK; Zealand University Hospital, Roskilde, DENMARK and Herlev-Gentofte Hospital, Copenhagen, Denmark, {5}Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, {6}Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany, {7}Duke Clinical Research Institute, Durham, NC, and Duke University Medical Center, Department of Medicine, Division of Cardiology, Durham, NC, {8}Obesity Research Unit, Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki and Healthy Weight Hub, Abdominal Center, Helsinki University Hospital, Helsinki, Finland, {9}Department of Cardiology, Herlev-Gentofte Hospital, Herlev, Denmark, {10}School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, United Kingdom, {11}The Obesity and Metabolism Institute, Boston, MA, USA, and Geisel School of Medicine at Dartmouth, Hanover, NH